These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31146595)

  • 21. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
    Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
    Koike H; Nishi R; Yagi S; Furukawa S; Fukami Y; Iijima M; Katsuno M
    Adv Ther; 2023 Jan; 40(1):25-40. PubMed ID: 36152266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab.
    Tsioulos G; Kounatidis D; Vallianou NG; Koufopoulos N; Katsimbri P; Antoniadou A
    Am J Med Sci; 2023 Jan; 365(1):93-98. PubMed ID: 35970248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
    Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of therapeutic activity of mepolizumab.
    Cavaliere C; Frati F; Ridolo E; Greco A; de Vincentiis M; Masieri S; Makri E; Incorvaia C
    Expert Rev Clin Immunol; 2019 Sep; 15(9):959-967. PubMed ID: 31424304
    [No Abstract]   [Full Text] [Related]  

  • 28. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
    Wechsler ME; Akuthota P; Jayne D; Khoury P; Klion A; Langford CA; Merkel PA; Moosig F; Specks U; Cid MC; Luqmani R; Brown J; Mallett S; Philipson R; Yancey SW; Steinfeld J; Weller PF; Gleich GJ;
    N Engl J Med; 2017 May; 376(20):1921-1932. PubMed ID: 28514601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis.
    Bloom JL; Langford CA; Wechsler ME
    Rheum Dis Clin North Am; 2023 Aug; 49(3):563-584. PubMed ID: 37331733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
    Bayrak Durmaz MS; Çelebi Sözener Z; Bavbek S
    Tuberk Toraks; 2022 Mar; 70(1):93-101. PubMed ID: 35362309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis.
    Pagnoux C; Berti A
    Expert Opin Pharmacother; 2023; 24(11):1269-1281. PubMed ID: 37204027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eosinophilic granulomatosis with polyangiitis: A review.
    White J; Dubey S
    Autoimmun Rev; 2023 Jan; 22(1):103219. PubMed ID: 36283646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
    Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
    Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Moosig F; Holle J
    Z Rheumatol; 2019 May; 78(4):333-338. PubMed ID: 30627842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Nara M; Saito M; Abe F; Komatsuda A; Wakui H; Takahashi N
    Intern Med; 2019 Dec; 58(24):3583-3587. PubMed ID: 31391393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.
    Nanzer AM; Maynard-Paquette AC; Alam V; Green L; Thomson L; Lam J; Fernandes M; Roxas C; d'Ancona G; Hearn A; Gates J; Agarwal S; Kent BD; Fernando M; D'Cruz DP; Hopkins C; Ismail TF; Dhariwal J; Jackson DJ
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):724-732. PubMed ID: 38211889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
    Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
    Tsurikisawa N; Oshikata C; Watanabe M; Fukuda N; Yamaguchi T; Kiyohara H; Kaneko T
    Int Arch Allergy Immunol; 2021; 182(8):744-756. PubMed ID: 33887721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations.
    Watanabe R; Hashimoto M
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
    Manka LA; Guntur VP; Denson JL; Dunn RM; Dollin YT; Strand MJ; Wechsler ME
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):696-701.e1. PubMed ID: 33548468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.